A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

431

Participants

Timeline

Start Date

February 7, 2012

Primary Completion Date

August 1, 2015

Study Completion Date

July 11, 2016

Conditions
Bipolar Disorder
Interventions
DRUG

FK949E

Taken by mouth (orally).

DRUG

Placebo

Taken by mouth (orally).

Trial Locations (98)

Unknown

Site JP00030, Aichi

Site JP00031, Aichi

Site JP00052, Aichi

Site JP00055, Aichi

Site JP00072, Aichi

Site JP00092, Aichi

Site JP00003, Akita

Site JP00008, Chiba

Site JP00009, Chiba

Site JP00002, Fukuoka

Site JP00037, Fukuoka

Site JP00038, Fukuoka

Site JP00039, Fukuoka

Site JP00040, Fukuoka

Site JP00041, Fukuoka

Site JP00058, Fukuoka

Site JP00082, Fukuoka

Site JP00083, Fukuoka

Site JP00091, Fukuoka

Site JP00094, Fukuoka

Site JP00095, Fukuoka

Site JP00096, Fukuoka

Site JP00097, Fukuoka

Site JP00098, Fukuoka

Site JP00004, Fukushima

Site JP00028, Gifu

Site JP00006, Gunma

Site JP00007, Gunma

Site JP00035, Hiroshima

Site JP00056, Hiroshima

Site JP00067, Hiroshima

Site JP00001, Hokkaido

Site JP00059, Hokkaido

Site JP00061, Hokkaido

Site JP00062, Hokkaido

Site JP00068, Hokkaido

Site JP00069, Hokkaido

Site JP00073, Hokkaido

Site JP00074, Hokkaido

Site JP00076, Hokkaido

Site JP00005, Ibaraki

Site JP00049, Kagawa

Site JP00021, Kanagawa

Site JP00022, Kanagawa

Site JP00023, Kanagawa

Site JP00024, Kanagawa

Site JP00025, Kanagawa

Site JP00042, Kumamoto

Site JP00050, Kumamoto

Site JP00032, Kyoto

Site JP00084, Kyoto

Site JP00077, Miyagi

Site JP00027, Nagano

Site JP00075, Nara

Site JP00054, Okayama

Site JP00079, Okayama

Site JP00043, Okinawa

Site JP00046, Okinawa

Site JP00033, Osaka

Site JP00034, Osaka

Site JP00047, Osaka

Site JP00063, Osaka

Site JP00053, Ōita

Site JP00029, Shizuoka

Site JP00036, Tokushima

Site JP00010, Tokyo

Site JP00011, Tokyo

Site JP00012, Tokyo

Site JP00013, Tokyo

Site JP00014, Tokyo

Site JP00015, Tokyo

Site JP00016, Tokyo

Site JP00017, Tokyo

Site JP00018, Tokyo

Site JP00019, Tokyo

Site JP00020, Tokyo

Site JP00045, Tokyo

Site JP00048, Tokyo

Site JP00051, Tokyo

Site JP00057, Tokyo

Site JP00060, Tokyo

Site JP00064, Tokyo

Site JP00065, Tokyo

Site JP00066, Tokyo

Site JP00070, Tokyo

Site JP00071, Tokyo

Site JP00078, Tokyo

Site JP00081, Tokyo

Site JP00085, Tokyo

Site JP00086, Tokyo

Site JP00087, Tokyo

Site JP00088, Tokyo

Site JP00089, Tokyo

Site JP00090, Tokyo

Site JP00093, Tokyo

Site JP00099, Tokyo

Site JP00044, Tottori

Site JP00026, Toyama

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY